Target intelligence / Profile preview

RNA polymerase II associated protein 2 (RPAP2)

Target
RPAP2
Molecular classification
Enzyme (specifically, protein phosphatase), Transcription regulator, Other (Nuclear import factor for RNA polymerase II)
01

Overview

RNA polymerase II associated protein 2 (RPAP2) is a protein phosphatase and transcription regulatory factor that binds to and regulates RNA polymerase II, the central enzyme responsible for mRNA synthesis in eukaryotes[1][2][4][7]. RPAP2 primarily functions by dephosphorylating serine residues (notably Ser-5) in the C-terminal domain (CTD) of Pol II, thus promoting or fine-tuning transcription initiation and elongation, especially of small nuclear RNA (snRNA) genes[2][7]. It recognizes phosphorylated Ser-7 of the CTD, influencing both transcriptional activity and RNA processing[2]. Structurally, RPAP2 binds between the jaw domains of the Pol II subunits RPB1 and RPB5, and is involved in nuclear import of RNA polymerase II[1]. RPAP2 is displaced from Pol II during the formation of the transcription pre-initiation complex and upon DNA engagement, consistent with its role in regulating Pol II assembly and nuclear transport rather than ongoing transcription[1][3]. In addition to its role in transcription, RPAP2 participates in the unfolded protein response by dephosphorylating ER stress sensors, with implications for cell fate under ER stress conditions[2]. The yeast homolog of RPAP2, Rtr1, shares similar functions but varies in phosphatase activity depending on the species[1]. As of now, RPAP2 is not a recognized therapeutic target, and no drugs are known to act directly on it. There are no reports of RPAP2 serving as a clinically actionable biomarker or significant safety concerns associated with its manipulation[2][4][7].

Other names
RPAP2C1orf82Rtr1FLJ13150Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2RNA polymerase II-associated protein 2
02

Biological functions

Regulation of RNA polymerase II-dependent transcription through CTD dephosphorylationNuclear import of RNA polymerase IIRegulation of snRNA gene transcriptionModulation of unfolded protein response (UPR)Regulation of apoptosis via ER stress pathways
03

Disease associations

Cholestasis, intrahepatic, of pregnancy, 1Other (no widespread evidence for major roles in cancer, inflammation, or neurodegeneration as of current knowledge)

Beyond the preview

Go deeper on RNA polymerase II associated protein 2 (RPAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase II associated protein 2 (RPAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call